Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis (Q46140186)
scientific article published in February 2009
Language:
(P31) (Q13442814)
(P50) (Q47262894)
(Q91720749)
(P304) 335-344
(P407) (Q1860)
(P433) 2
(P478) 60
(P577) Sunday, February 1, 2009
(P921) (Q181600)
(Q27162644)
(Q187255)
(Q422232)
(P1433) (Q4797636)
(P1476) "Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis" (language: en)
(P2093) Tien-Tsai Cheng
Vishala Chindalore
Nemanja Damjanov
Ruben Burgos-Vargas
Patricia Delora
Kathleen Zimany
Helen Travers
John P Caulfield
other details
description scientific article published in February 2009

External Links